Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases
Clinical trial NCT00390468 · COMPLETED
Trial details
- NCT number
- NCT00390468
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2009-11-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.